Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 31/10/2014 → 30/04/2018 |
Collaborative partners
- King's College London (lead)
- ChemoCentryx, Inc.
Funding
- MRC Medical Research Council: £464,744.00
Targeting C5aR in chronic inflammation, renal fibrosis and late graft dysfunction
- Zhou, Wuding (Primary Investigator)
- Rebollo-Mesa, Irene (Co-Investigator)
- Sacks, Steven (Co-Investigator)
Project: Research